<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4B8017E5-40E0-4ED8-9216-7010746F9003"><gtr:id>4B8017E5-40E0-4ED8-9216-7010746F9003</gtr:id><gtr:name>Institute of Cancer Research UK</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1A363E86-41D4-470F-8868-054F59B80DD2"><gtr:id>1A363E86-41D4-470F-8868-054F59B80DD2</gtr:id><gtr:name>VASTox Plc</gtr:name><gtr:address><gtr:line1>91 Milton Park</gtr:line1><gtr:city>Abingdon</gtr:city><gtr:postCode>OX14 4RY</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>UNITED KINGDOM</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7035AE5D-F006-4762-9959-D965363291F6"><gtr:id>7035AE5D-F006-4762-9959-D965363291F6</gtr:id><gtr:name>Merck</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5D55E165-233B-426B-B629-5FFC887C1004"><gtr:id>5D55E165-233B-426B-B629-5FFC887C1004</gtr:id><gtr:name>MRC Technology (MRCT)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4B8017E5-40E0-4ED8-9216-7010746F9003"><gtr:id>4B8017E5-40E0-4ED8-9216-7010746F9003</gtr:id><gtr:name>Institute of Cancer Research UK</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1A363E86-41D4-470F-8868-054F59B80DD2"><gtr:id>1A363E86-41D4-470F-8868-054F59B80DD2</gtr:id><gtr:name>VASTox Plc</gtr:name><gtr:address><gtr:line1>91 Milton Park</gtr:line1><gtr:city>Abingdon</gtr:city><gtr:postCode>OX14 4RY</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>UNITED KINGDOM</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7035AE5D-F006-4762-9959-D965363291F6"><gtr:id>7035AE5D-F006-4762-9959-D965363291F6</gtr:id><gtr:name>Merck</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5D55E165-233B-426B-B629-5FFC887C1004"><gtr:id>5D55E165-233B-426B-B629-5FFC887C1004</gtr:id><gtr:name>MRC Technology (MRCT)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B1FC1A1F-B29A-4BF4-81EE-5926F7A0E8CE"><gtr:id>B1FC1A1F-B29A-4BF4-81EE-5926F7A0E8CE</gtr:id><gtr:firstName>Mariann</gtr:firstName><gtr:surname>Bienz</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U105192713"><gtr:id>1E21D593-A970-4AD8-B0A6-26261BDC5D16</gtr:id><gtr:title>Wnt signalling and cancer</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U105192713</gtr:grantReference><gtr:abstractText>The Wnt/beta-catenin signalling pathway is highly conserved and plays a key role during the normal development and tissue homeostasis of animals. This pathway is also a major cancer pathway. In particular, most colorectal cancers are due to hyperactive Wnt pathway activity in the intestinal epithelium, caused by mutational inactivation of the Adenomatous Polyposis Coli (APC) tumour suppressor or by mutational activation of beta-catenin. 
Our aim is to understand the molecular and cell-biological events during Wnt signalling in normal and malignant cells. In focus are the molecular functions of positive regulators of the Wnt pathway that have potential as drug targets. These include Dishevelled, Pygo and BCL9, three ancient Wnt signalling components that were discovered in fruit flies, but whose roles in the transduction of the Wnt signal from the cell surface to the cell nucleus remain poorly understood. We are combining biochemical, biophysical and structural analysis of these proteins with functional tests in human cell lines and in whole-organism models such as fruit flies and mice. Our work will pave the way towards the discovery of Wnt pathway inhibitors for therapeutic intervention in cancer.</gtr:abstractText><gtr:technicalSummary>The Wnt/beta-catenin signalling pathway is ancient and plays a key role during the normal development and tissue homeostasis of animals. This pathway is often dysregulated in human cancer. In particular, most colorectal cancers are due to hyperactive beta-catenin signalling in the intestinal epithelium, caused by mutational inactivation of its negative regulator, the Adenomatous polyposis Coli (APC) tumour suppressor, or by mutational activation of beta-catenin itself. 
Our aim is to understand the molecular and cell-biological mechanisms underlying the transduction of the Wnt signal from the plasma membrane to the nucleus in normal and malignant cells. In focus are the molecular functions of positive regulators of the Wnt pathway that have potential as drug targets, including Dishevelled and the Pygo-BCL9 complex. Our main questions are how Dishevelled assembles Wnt signalosomes to inactivate the Axin-APC complex, and how the Pygo-BCL9 complex enables the Wnt enhanceosome to activate beta-catenin-mediated transcription. Our approach is to combine biochemical, biophysical and structural analysis of these proteins with cell-biological analysis and functional assays in mammalian cell lines (including colorectal cancer cells) and in whole-organism models such as Drosophila and mice. We have also been awarded a CRUK programme grant to develop the potential of these Wnt signalling components as drug targets and to examine their regulation by the ubiquitin system.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-05-11</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>7686482</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Institute of Cancer Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Breakthrough Toby Robins Breast Cancer Research Centre</gtr:department><gtr:description>Trabid collaboration</gtr:description><gtr:id>004BAA46-A0FF-4844-BC45-7249EC6FD65D</gtr:id><gtr:impact>Not yet known (collaboration ongoing)</gtr:impact><gtr:outcomeId>5463454e3fb8e9.64363847-1</gtr:outcomeId><gtr:partnerContribution>Analysing the function of Trabid in the innate immune response of Drosophila and mouse intestines</gtr:partnerContribution><gtr:piContribution>Analysing the function of Trabid in safeguarding homeostasis of the Drosophila intestine
Generating Trabid knock-out mice (Zranb1 -/-)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>VASTox Plc</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Armadillo fly model</gtr:description><gtr:id>66FC2876-8DD2-4D87-9101-82A55F4D4274</gtr:id><gtr:impact>Vastox were interested in trying out the Armadillo fly model that we have developed and used successfully to identify Pygo (a new Wnt signalling component)</gtr:impact><gtr:outcomeId>04F087AF00D-1</gtr:outcomeId><gtr:partnerContribution>Used Armadillo fly strain for small molecule inhibitor screens</gtr:partnerContribution><gtr:piContribution>Material Transfer Agreement - licensed Armadillo fly strains</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>Activation of a HECT domain E3 ubiquitin ligase by Dishevelled</gtr:description><gtr:id>0558E657-2820-4D2B-800C-A91F2344BD87</gtr:id><gtr:impact>publication</gtr:impact><gtr:outcomeId>56dee7d76a8f01.39723720-1</gtr:outcomeId><gtr:partnerContribution>Scientific</gtr:partnerContribution><gtr:piContribution>Scientific</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Technology (MRCT)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with MRC Technology</gtr:description><gtr:id>E1551D68-37AA-4FCE-8E75-A7EF31A146A5</gtr:id><gtr:impact>This work has been published (including a crystal structure of a compound bound to Pygo2 PHD)</gtr:impact><gtr:outcomeId>5463434b4f68f5.49719399-1</gtr:outcomeId><gtr:partnerContribution>In silico screens for small molecules binding to the histone-binding surface of the Pygo PHD finger</gtr:partnerContribution><gtr:piContribution>Validations of in silico hits and SAR compounds by NMR, and NMR screening for chemical fragments binding to the PHD finger from human Pygo2</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Clinical Pharmacology Unit</gtr:department><gtr:description>?-catenin functions in the human adrenal</gtr:description><gtr:id>9308490D-66D4-4B55-8551-68AECF462875</gtr:id><gtr:impact>publication</gtr:impact><gtr:outcomeId>56deea71808d48.89594519-1</gtr:outcomeId><gtr:partnerContribution>Scientific</gtr:partnerContribution><gtr:piContribution>Scientific</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Merck</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>MilliporeSigma</gtr:department><gtr:description>Production of Trabid antiserum</gtr:description><gtr:id>A6695DC4-099F-4943-9DCC-E0D49E070631</gtr:id><gtr:impact>Millipore was interested in producing an antiserum against Trabid, as previously validated by us, for sale</gtr:impact><gtr:outcomeId>2112165A7A6-1</gtr:outcomeId><gtr:partnerContribution>Production of antiserum against human Trabid (ABS13) and validation</gtr:partnerContribution><gtr:piContribution>Collaboration agreement - providing recombinant human Trabid protein for production of Trabid (Znrb1) antiserum</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>Ubiquitylation of the Dishevelled DIX domain</gtr:description><gtr:id>4D89729F-083E-446D-9739-ADDB69FD3D55</gtr:id><gtr:impact>publication</gtr:impact><gtr:outcomeId>56dee64ff3ea77.58462890-1</gtr:outcomeId><gtr:partnerContribution>Scientific</gtr:partnerContribution><gtr:piContribution>Ubiquitylation of the Dishevelled DIX domain</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Chair of Royal Society Partnership Grants Committee</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>18ED412B-B6C5-43A0-A2BE-E9980628BDB0</gtr:id><gtr:impact>Selecting applications for funding for partnerships projects between schools and academic scientists

Promoting science eduction in schools; stimulating interest of pupils in scientific research</gtr:impact><gtr:outcomeId>546363980bb352.34552139</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit to Royal Society London</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>210162FA-4E23-43CE-A4FC-34F1F4003D16</gtr:id><gtr:impact>Taking 15 GSCE triple science students to the Royal Society Annual Summer Exhibition in London, to inspire them for science

School reports higher levels of interest in continuing with science beyond GCSE</gtr:impact><gtr:outcomeId>FJrCtzzQDvc</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>Pre-2006,2006,2007,2008,</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CR-UK Clinical Fellowship Selection Panel</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E6A50437-A76C-4D8E-88E1-E092C5EB43A8</gtr:id><gtr:impact>Selecting fellowship applicants from clinicians for award

Promoting early academic research careers of clinicians</gtr:impact><gtr:outcomeId>54636588a96712.64154467</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Scientific Advisory Board of the Centre for Integrative Genomics, Lausanne (Switzerland)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CF50D306-A3BD-4C51-9067-CF30EBF907A8</gtr:id><gtr:impact>Advising the Director of this Centre on funding, recruitment and tenure decisions of research staff, and student and postdoctoral training</gtr:impact><gtr:outcomeId>56e0056107f4c5.90857724</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Institute Management Committee of the Cambridge Institute for Medical Research</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>CCAC912F-BA46-4806-84E1-4ADD36216BC1</gtr:id><gtr:impact>Advising the Director of this Institute on management issues, recruitment and tenure decisions of research staff</gtr:impact><gtr:outcomeId>56e006fd15be59.06087653</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>LMB Offical Royal Opening</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DBC2507E-FDF9-47A3-AB43-B00FD999B0A9</gtr:id><gtr:impact>Local media and press were invited to the opening of the new LMB building by HM the Queen. I liaised with a local primary school to arrange for 40 pupils to greet the Queen as she arrived at the LMB - an opportunity to enable participation of local school children and strengthen links with the local community.

Considerable local and national press coverage</gtr:impact><gtr:outcomeId>pHP9pY83MBB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society Education Committee</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>04795C0A-624A-4872-A21E-458D3C37FE7C</gtr:id><gtr:impact>This committee primarily seeks to impact on education policies in the UK (e.g. by implementing 'Vision')</gtr:impact><gtr:outcomeId>56e0015932b8c8.79520408</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society Sectional Committee 7</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5248F7F3-71FB-47AD-A94B-1B1771E4D12F</gtr:id><gtr:impact>Selects Fellows of the Royal Society</gtr:impact><gtr:outcomeId>56e007fd924870.44807537</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Raconteur for 'Telling Tales on Women in Science'</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E799FE70-2F2E-4AC2-83E4-118A83F1F824</gtr:id><gtr:impact>Raconteur for 'Telling Tales on Women in Science', launched by MRC Clinical Sciences Centre to commemorate 100 years of International Women's Day</gtr:impact><gtr:outcomeId>56defa8bd851b6.47574230</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society Dorothy Hodgkin Fellowship Panel</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2A86C2D4-8694-4220-8602-C1C0EA4FDC6C</gtr:id><gtr:impact>Assessing fellowship applications and deciding on awards

Promoting early careers of women in science</gtr:impact><gtr:outcomeId>546361bac518d6.08930006</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Keystone Symposium on Development Pathways and Cancer: Wnt, Notch and Hedgehog</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AD2471D5-BFD9-49A5-BD7B-94A293B27614</gtr:id><gtr:impact>Talk resulted in discussions with peers and networking

Not yet known</gtr:impact><gtr:outcomeId>5460dc3505f7e7.98825719</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Scientific Advisory Board for Spanish National Research Cancer Centre</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1382703A-AB54-422B-8E1A-FA15D9F3F73C</gtr:id><gtr:impact>Chairing this international Advisory Board which advises the Director of this National Research Institute and the Spanish Science Minister on funding, recruitments and tenure decisions of research staff, and student and postdoctoral training</gtr:impact><gtr:outcomeId>56e0045a4a7320.54730073</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012,2013,2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society Summer Science Exhibition Committee</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>060C7664-9283-4694-B86B-F333E413BD69</gtr:id><gtr:impact>Selecting applications for Royal Society Summer Exhibition

Educating public understanding of science; stimulating interest in scientific research</gtr:impact><gtr:outcomeId>54636476e2e697.18949929</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society Working Group on Eligibility</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CA1E733C-FFBE-4359-9600-63CF6906994C</gtr:id><gtr:impact>Royal Society Working Group on Eligibility</gtr:impact><gtr:outcomeId>58ca724bdb5923.26245589</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society Panel for International Scientific Collaboration Awards, Chair</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FDCE6F54-CF1E-47A1-A675-76F0055AC0B2</gtr:id><gtr:impact>Chairperson on Royal Society Panel for International Scientific Collaboration Awards</gtr:impact><gtr:outcomeId>58ca71f59a5ce5.64067818</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2013 LMB Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>35D337B3-BFC8-47C9-BD2D-CEE4150CA7B3</gtr:id><gtr:impact>Over 2,000 members of the public including over 600 children attended the Open Day on 22 June 2013.

Feedback was extremely positive including requests for similar events in future. The level of interest from the public was much higher than expected.</gtr:impact><gtr:outcomeId>dbRLG1Q6NtR</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Taking School Children to Royal Society Summer Exhibition</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>2E87776E-F324-44B7-831A-A7F653493ECF</gtr:id><gtr:impact>Took 16 year 10 children to the Royal Society Summer Exhibition</gtr:impact><gtr:outcomeId>58bec6dd8a5296.78035866</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EMBO Workshop on Wnt Signalling</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1E4EC9B7-47CA-4594-87FD-F4D6922D4876</gtr:id><gtr:impact>Talk resulted in dicussions with peers and networking

No yet known</gtr:impact><gtr:outcomeId>5460dca26d70d6.17803821</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Scientific Advisory Board of the CRUK Cambridge Research Institute</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>C22165EB-3C7C-43A0-A75D-7576E32EC2C5</gtr:id><gtr:impact>Advising the Director of this Cancer Research UK Institute on funding, recruitment and tenure decisions of research staff, and student and postdoctoral training</gtr:impact><gtr:outcomeId>56e00641597902.11265292</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cancer Research UK Science Committee</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>71B0F23C-F786-4668-B860-A3CBA6B22065</gtr:id><gtr:impact>On Cancer Research UK Science Committee</gtr:impact><gtr:outcomeId>58ca714a4fc982.00035304</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>LMB Alumni Symposium</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5D9707DE-B880-4F2C-8943-15FCD82F3CF3</gtr:id><gtr:impact>Talk was followed by question and discussion

Not yet known</gtr:impact><gtr:outcomeId>546334f3da0664.86405777</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Women in Science - Wikipedia Edit-athon at LMB</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>96BB8F23-D932-4C1D-ADBA-729FA05042E0</gtr:id><gtr:impact>Wiki entries for women scientists updated (including Bienz)

Not yet known</gtr:impact><gtr:outcomeId>5460d66b491a76.58598054</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>152937</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AICR Project Grant</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>Association for International Cancer Research (AICR)</gtr:fundingOrg><gtr:id>C5B375F3-9B0F-4FF9-A89B-B15576E909BD</gtr:id><gtr:outcomeId>C20C545AE2B0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>509855</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Programme Grant</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:fundingRef>C7379/A8709</gtr:fundingRef><gtr:id>0AC9F18A-E58F-414E-82F1-2ECE69E66C29</gtr:id><gtr:outcomeId>CC9EE0695300</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>608273</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Programme Award 2012</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:fundingRef>A15291</gtr:fundingRef><gtr:id>AD98C111-207A-4839-BDE9-895C4D3BCC7E</gtr:id><gtr:outcomeId>UfhXcZyP8Fa</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>28175</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRCT Development Gap Funding</gtr:description><gtr:end>2009-08-02</gtr:end><gtr:fundingOrg>MRC Technology (MRCT)</gtr:fundingOrg><gtr:id>0DA409BD-6A4D-4AB3-9872-A1788402A5EE</gtr:id><gtr:outcomeId>54455123CD30</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>147000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Cambridge/Barts Molecular Pathology Training Programme</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:fundingRef>C10112/A11388</gtr:fundingRef><gtr:id>36B317A2-D237-4E9B-999F-C480F586C2F6</gtr:id><gtr:outcomeId>twWSrhMxGxr</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>89325</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cancer Centre Studentship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>University of Cambridge</gtr:fundingOrg><gtr:id>273981D7-5693-4AD8-85AF-0BABF9822763</gtr:id><gtr:outcomeId>SurfFopAcnM</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>PCT Patent Application, Priority filing May 26th 2006
Published WO/2007/GB01839 &amp;amp; PCT/GB2007/001839
Granted 1117774 (Europe) 29/08/2012</gtr:description><gtr:grantRef>MC_U105192713</gtr:grantRef><gtr:id>53DD7D86-4021-4A99-9CA7-79200FF4CDF6</gtr:id><gtr:impact>Describes the case for (1) the Trabid de-ubiquitylase as a putative target for therapeutic interference in colorectal cancer and other types of cancer and (2) the use of its three tandem NZF fingers as a tool for recognising specific non-canonical ubiquitin linkages</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>MZsoWd132s2</gtr:outcomeId><gtr:patentId>WO2007138253</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>UK Patent application No. 0610542.3 'Screening Method'</gtr:title><gtr:yearProtectionGranted>2007</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Coordinates of the crystal structure of the human Pygo2-B9L PHD-HD1 complex</gtr:description><gtr:id>A3BE0F4F-F022-4C09-BF5E-EC36FD7A7586</gtr:id><gtr:impact>Basis for future cancer drug development (colorectal cancer)</gtr:impact><gtr:outcomeId>CB4Qv8VteWG</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Pygo2-B9L X-ray structure</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>X-ray coordinates of benzothiazole compound CF4 bound to its cleft in the PHD finger of human Pygo2 (Protein Data Base entry 4UP5)</gtr:description><gtr:id>D71AB203-8663-4E47-B570-22FACC295B5E</gtr:id><gtr:impact>Providing proof-of-concept for the discovery of small molecules binding to the Pygo PHD finger</gtr:impact><gtr:outcomeId>54633e213a03e2.18768414</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>X-ray structure of benzothiazole bound to Pygo PHD</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>X-ray coordinates for ternary complex between human Pygo2_PHD, B9L_HD1 and H3K4me2K9ac (Protein Data Base entry 4UP0)</gtr:description><gtr:id>792F566B-AD71-40AE-B6A7-4F19303BB94E</gtr:id><gtr:impact>Contributes to knowledge about chromatin decoding by nuclear Wnt factors</gtr:impact><gtr:outcomeId>54633cb5bf0841.30099906</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>X-ray structure of ternary Pygo2-B9L complex with modified histone H3 tail peptide</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Coordinates of the crystal structure of the Pygo-BCL9 PHD-HD1 complex</gtr:description><gtr:id>3ABCB68D-8374-4AA0-8FF6-635BF832910B</gtr:id><gtr:impact>Basis for future drug development</gtr:impact><gtr:outcomeId>63D237D8506</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Pygo-BCL9 X-ray structure</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Accession codes 3SLA and 3SL9</gtr:description><gtr:id>B42C3FD7-BD7E-434E-BC1B-B99CF32B3B8F</gtr:id><gtr:impact>High-resolution structure of a potential drug target in the Wnt signalling pathway</gtr:impact><gtr:outcomeId>ZzkDUB1yFGD</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>BCL9-beta-catenin structures</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>High-resolution structure of the catalytic OTU domain of Trabid flanked by its ubiquitin-binding Ankyrin Repeat domain

Accession code 3ZRH</gtr:description><gtr:id>64D8E6B5-84C3-44F3-AA10-1AA0DD73A15B</gtr:id><gtr:impact>Structural description of the active site of a de-ubiquitylating enzyme, a putative drug target in the Wnt signalling pathway</gtr:impact><gtr:outcomeId>npZrqZPDFdS</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Trabid X-ray structure</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Coordinates of the X-ray structure of the PHD-HD1 complex from Drosophila Pygopus and Legless (Protein Data Bank accession code 3zpv)</gtr:description><gtr:id>88A510F8-E5BE-4C48-8960-6E15F8B86A63</gtr:id><gtr:impact>Contributing to knowledge of chromatin decoding</gtr:impact><gtr:outcomeId>shqi5WuP5Vn</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Pygopus-Legless complex structure</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Drosophila strains expressing activated (oncogenic) Armadillo in the eye imaginal disc</gtr:description><gtr:id>825888CA-BE15-40CA-8B38-E85705D1E287</gtr:id><gtr:impact>This strain was provided to other Drosophila laboratories world-wide, and was licensed to a company (Vastox plc)</gtr:impact><gtr:outcomeId>683AC5079D1</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Armadillo fly strain</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F779AF8C-8A70-4B6F-9662-B31E5C88306C</gtr:id><gtr:title>Essential role of the Dishevelled DEP domain in a Wnt-dependent human-cell-based complementation assay.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8ebe07917c448426c03efb6546f8fd9"><gtr:id>d8ebe07917c448426c03efb6546f8fd9</gtr:id><gtr:otherNames>Gammons MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>585d3db90fda52.56377554</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13C30839-342F-4F3B-8AD6-2D95417103CE</gtr:id><gtr:title>The DIX domain of Dishevelled confers Wnt signaling by dynamic polymerization.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fd31a2e02637bb0df99f4805924100a"><gtr:id>4fd31a2e02637bb0df99f4805924100a</gtr:id><gtr:otherNames>Schwarz-Romond T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>5FBC576565E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B2D75E3-CCB1-47FF-8F4C-F14C4948C26C</gtr:id><gtr:title>An ancient Pygo-dependent Wnt enhanceosome integrated by Chip/LDB-SSDP.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c522a1382f138dd719163b9e92aabe9"><gtr:id>3c522a1382f138dd719163b9e92aabe9</gtr:id><gtr:otherNames>Fiedler M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>56decfce0acb96.39602934</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52532D20-80F9-466C-B074-255F5EA5888D</gtr:id><gtr:title>The Adenomatous polyposis coli tumour suppressor is essential for Axin complex assembly and function and opposes Axin's interaction with Dishevelled.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77d590be2b824225bda94e3937772b35"><gtr:id>77d590be2b824225bda94e3937772b35</gtr:id><gtr:otherNames>Mendoza-Topaz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>pm_15124_24_22645652</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DEE5180-10EA-4546-9B77-140523014675</gtr:id><gtr:title>Wnt-Dependent Inactivation of the Groucho/TLE Co-repressor by the HECT E3&amp;nbsp;Ubiquitin Ligase Hyd/UBR5.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ca0ab6f5ad28fb2fb0fbb30b34fc1cd"><gtr:id>6ca0ab6f5ad28fb2fb0fbb30b34fc1cd</gtr:id><gtr:otherNames>Flack JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>5a9c1e1e8384c1.98549157</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0D047A6-67D8-4342-8085-053E531C0836</gtr:id><gtr:title>Transcriptional regulation of Wnt inhibitory factor-1 by Miz-1/c-Myc.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82611df54c3ff0653b2e0226cb3539e9"><gtr:id>82611df54c3ff0653b2e0226cb3539e9</gtr:id><gtr:otherNames>Licchesi JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>cKZtmnBSddD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1FD21C4-5B1A-4467-B5C1-E64BB17598AF</gtr:id><gtr:title>Ubiquitination of the Dishevelled DIX domain blocks its head-to-tail polymerization.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f6b3e2bcaf131afbff3b9bbcd79839d"><gtr:id>3f6b3e2bcaf131afbff3b9bbcd79839d</gtr:id><gtr:otherNames>Madrzak J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56dc468aab7801.94222971</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36DB1CF8-7322-443C-BFBA-77A7914D6D5E</gtr:id><gtr:title>Evolutionary adaptation of the fly Pygo PHD finger toward recognizing histone H3 tail methylated at arginine 2.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac9e555a6cb727d7db9f02a175d55145"><gtr:id>ac9e555a6cb727d7db9f02a175d55145</gtr:id><gtr:otherNames>Miller TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>5460c9dae99d49.04832760</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C105952-EF2F-4970-8939-10DD0584E75D</gtr:id><gtr:title>Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists.</gtr:title><gtr:parentPublicationTitle>BMC cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0b1e6f5c7a781cb41f9a3b92fd66184"><gtr:id>a0b1e6f5c7a781cb41f9a3b92fd66184</gtr:id><gtr:otherNames>Silva AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2407</gtr:issn><gtr:outcomeId>56dc4646d73899.40784426</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>213426D0-662C-4BF1-A19A-A763F7070A1D</gtr:id><gtr:title>Dishevelled interacts with the DIX domain polymerization interface of Axin to interfere with its function in down-regulating ?-catenin.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c522a1382f138dd719163b9e92aabe9"><gtr:id>3c522a1382f138dd719163b9e92aabe9</gtr:id><gtr:otherNames>Fiedler M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>1AF302A3_C1AF302A3_C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD352A9D-DB04-442C-BC0F-5A9F9926D643</gtr:id><gtr:title>Disinhibition of the HECT E3 ubiquitin ligase WWP2 by polymerized Dishevelled.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcdc18642a23f6b5bf0fc45ac26ad209"><gtr:id>bcdc18642a23f6b5bf0fc45ac26ad209</gtr:id><gtr:otherNames>Mund T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>56decf596e3990.29487835</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85E40F63-C214-476C-9F8A-ABA253E448F2</gtr:id><gtr:title>The PHD finger, a nuclear protein-interaction domain.</gtr:title><gtr:parentPublicationTitle>Trends in biochemical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c8a79086535aadbe23c2520c1336215"><gtr:id>0c8a79086535aadbe23c2520c1336215</gtr:id><gtr:otherNames>Bienz M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0968-0004</gtr:issn><gtr:outcomeId>E82F96D95A2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>005DA63D-38F5-4B1D-93CC-B800602FE158</gtr:id><gtr:title>Competitive binding of a benzimidazole to the histone-binding pocket of the Pygo PHD finger.</gtr:title><gtr:parentPublicationTitle>ACS chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac9e555a6cb727d7db9f02a175d55145"><gtr:id>ac9e555a6cb727d7db9f02a175d55145</gtr:id><gtr:otherNames>Miller TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1554-8929</gtr:issn><gtr:outcomeId>5460cad23869b6.48241416</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90FCA79A-E3D1-4F44-A74B-1EEA4E2771F1</gtr:id><gtr:title>Wnt Signalosome Assembly by DEP Domain Swapping of Dishevelled.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8ebe07917c448426c03efb6546f8fd9"><gtr:id>d8ebe07917c448426c03efb6546f8fd9</gtr:id><gtr:otherNames>Gammons MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>58bd5effe01f11.51236125</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67AF403B-59EB-4936-8533-7B82191EF673</gtr:id><gtr:title>Allosteric remodelling of the histone H3 binding pocket in the Pygo2 PHD finger triggered by its binding to the B9L/BCL9 co-factor.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac9e555a6cb727d7db9f02a175d55145"><gtr:id>ac9e555a6cb727d7db9f02a175d55145</gtr:id><gtr:otherNames>Miller TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>b5RcpEBhVeg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CECC5602-3722-4FCF-A8DF-9B8314D764FD</gtr:id><gtr:title>A role of Pygopus as an anti-repressor in facilitating Wnt-dependent transcription.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d57d535ef523f4618f4f0a5ab9b1e62d"><gtr:id>d57d535ef523f4618f4f0a5ab9b1e62d</gtr:id><gtr:otherNames>Mieszczanek J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>441EFADCC0D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBA78FF6-2E19-486E-9459-2E62681F8067</gtr:id><gtr:title>Decoding of methylated histone H3 tail by the Pygo-BCL9 Wnt signaling complex.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c522a1382f138dd719163b9e92aabe9"><gtr:id>3c522a1382f138dd719163b9e92aabe9</gtr:id><gtr:otherNames>Fiedler M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>FC37692BF83</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B0282B4-6C99-46F2-9AAB-B98A874866FE</gtr:id><gtr:title>Trabid, a new positive regulator of Wnt-induced transcription with preference for binding and cleaving K63-linked ubiquitin chains.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/caec3d7022318bd3505166efe4513122"><gtr:id>caec3d7022318bd3505166efe4513122</gtr:id><gtr:otherNames>Tran H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>77A88AAC340</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D6EF992-59EF-4A25-B7A4-76C7269EB43E</gtr:id><gtr:title>An intrinsically labile a-helix abutting the BCL9-binding site of ?-catenin is required for its inhibition by carnosic acid.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78fe2c32ff9eac9f043fa9730d79f513"><gtr:id>78fe2c32ff9eac9f043fa9730d79f513</gtr:id><gtr:otherNames>de la Roche M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_15124_24_22353711</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45AEF2B9-F48E-4F17-8056-0A91F85688C8</gtr:id><gtr:title>Pregnancy, Primary Aldosteronism, and Adrenal CTNNB1 Mutations.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eece961588d09b268ea46ab7d8fbdf0a"><gtr:id>eece961588d09b268ea46ab7d8fbdf0a</gtr:id><gtr:otherNames>Teo AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>56dc47d30abd34.55397653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44C5E673-7B85-4634-AA0B-31F224874CBE</gtr:id><gtr:title>An ankyrin-repeat ubiquitin-binding domain determines TRABID's specificity for atypical ubiquitin chains.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82611df54c3ff0653b2e0226cb3539e9"><gtr:id>82611df54c3ff0653b2e0226cb3539e9</gtr:id><gtr:otherNames>Licchesi JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>pm_15124_24_22157957</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>749D997E-F332-4420-B044-39BE79868C81</gtr:id><gtr:title>The function of BCL9 in Wnt/beta-catenin signaling and colorectal cancer cells.</gtr:title><gtr:parentPublicationTitle>BMC cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78fe2c32ff9eac9f043fa9730d79f513"><gtr:id>78fe2c32ff9eac9f043fa9730d79f513</gtr:id><gtr:otherNames>de la Roche M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-2407</gtr:issn><gtr:outcomeId>C0E6F4298AC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96600D2E-9F8B-4297-B16F-F2E0866402FE</gtr:id><gtr:title>Biochemistry. A lipid linchpin for Wnt-Fz docking.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c8a79086535aadbe23c2520c1336215"><gtr:id>0c8a79086535aadbe23c2520c1336215</gtr:id><gtr:otherNames>Bienz M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_15124_24_22653728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF1B6E7A-4EA2-49E2-889E-941098780248</gtr:id><gtr:title>Dvl2 promotes intestinal length and neoplasia in the ApcMin mouse model for colorectal cancer.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d61a8e019181cfb919b7ee6f4053188"><gtr:id>4d61a8e019181cfb919b7ee6f4053188</gtr:id><gtr:otherNames>Metcalfe C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>Ne4cgtU7Zws</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED944200-C79C-4FB5-BDF3-63295FAC4925</gtr:id><gtr:title>Multiprotein complexes governing Wnt signal transduction.</gtr:title><gtr:parentPublicationTitle>Current opinion in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/927937bcf57222d38601f031dfe896fd"><gtr:id>927937bcf57222d38601f031dfe896fd</gtr:id><gtr:otherNames>Gammons M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0955-0674</gtr:issn><gtr:outcomeId>5a9c1d99a5a688.37753057</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>106F312C-8210-4C33-BFFA-0DF0A5B6A5C1</gtr:id><gtr:title>Signalosome assembly by domains undergoing dynamic head-to-tail polymerization.</gtr:title><gtr:parentPublicationTitle>Trends in biochemical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c8a79086535aadbe23c2520c1336215"><gtr:id>0c8a79086535aadbe23c2520c1336215</gtr:id><gtr:otherNames>Bienz M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0968-0004</gtr:issn><gtr:outcomeId>5460ca560e16d9.15176831</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75662B6C-0EF4-4A6B-9F0A-D7652C9BACFB</gtr:id><gtr:title>Histone modifications for chromatin dynamics and cellular plasticity.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c6e5e9778ed469661fa44c1c8bf04f6"><gtr:id>6c6e5e9778ed469661fa44c1c8bf04f6</gtr:id><gtr:otherNames>Kutateladze TG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>5aa279e772b9a1.16062303</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>036FB344-5980-47F1-A319-FAF195617E99</gtr:id><gtr:title>Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eae7edf2b98993c7ceb079ac3f6325f7"><gtr:id>eae7edf2b98993c7ceb079ac3f6325f7</gtr:id><gtr:otherNames>van Tienen LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>58ca730aa721f8.93482510</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB28DE69-AFD3-4DDF-8DF1-E38FD8654C9A</gtr:id><gtr:title>Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4602c6146783dde28c4bbf1c9994541d"><gtr:id>4602c6146783dde28c4bbf1c9994541d</gtr:id><gtr:otherNames>Bilic J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>4F1914B0595</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7739F4A7-05B7-41A7-9447-9930272355C0</gtr:id><gtr:title>LEF1 and B9L shield ?-catenin from inactivation by Axin, desensitizing colorectal cancer cells to tankyrase inhibitors.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78fe2c32ff9eac9f043fa9730d79f513"><gtr:id>78fe2c32ff9eac9f043fa9730d79f513</gtr:id><gtr:otherNames>de la Roche M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>5460c9dac34750.12297007</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1EF863C-D7E3-4DCD-8DF9-115B5F61EE03</gtr:id><gtr:title>Inhibition of GSK3 by Wnt signalling--two contrasting models.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d61a8e019181cfb919b7ee6f4053188"><gtr:id>4d61a8e019181cfb919b7ee6f4053188</gtr:id><gtr:otherNames>Metcalfe C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>rgfUEdtaAZQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F5CDB37-CADD-4150-8BE9-CB321E4E631F</gtr:id><gtr:title>Wingless-independent association of Pygopus with dTCF target genes.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78fe2c32ff9eac9f043fa9730d79f513"><gtr:id>78fe2c32ff9eac9f043fa9730d79f513</gtr:id><gtr:otherNames>de la Roche M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>4B988515FE2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCB83227-CC9B-403F-BA5D-C2DAE020E60E</gtr:id><gtr:title>Stability elements in the LRP6 cytoplasmic tail confer efficient signalling upon DIX-dependent polymerization.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d61a8e019181cfb919b7ee6f4053188"><gtr:id>4d61a8e019181cfb919b7ee6f4053188</gtr:id><gtr:otherNames>Metcalfe C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>BfXezmVbxp7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F17C31EF-97EC-4E84-80E2-3D8DC391DC8F</gtr:id><gtr:title>Dynamic recruitment of axin by Dishevelled protein assemblies.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fd31a2e02637bb0df99f4805924100a"><gtr:id>4fd31a2e02637bb0df99f4805924100a</gtr:id><gtr:otherNames>Schwarz-Romond T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>06EE8CF5563</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27E88AC6-73B7-4871-8440-3FE29601CDCA</gtr:id><gtr:title>Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46a1d0cdedcc95ccf3122feac0e4ff79"><gtr:id>46a1d0cdedcc95ccf3122feac0e4ff79</gtr:id><gtr:otherNames>Komander D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>aShGrTWdswM</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U105192713</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>